BCR-ABL kinase domain mutations and resistance in Ph+ acute lymphoblastic leukemia from the imatinib to the second-generation TKI era.
Simona Soverini
No relevant relationships to disclose
Alessandra Gnani
No relevant relationships to disclose
Caterina De Benedittis
No relevant relationships to disclose
Ilaria Iacobucci
No relevant relationships to disclose
Claudia Venturi
No relevant relationships to disclose
Cristina Papayannidis
No relevant relationships to disclose
Mario Luppi
No relevant relationships to disclose
Serena Merante
No relevant relationships to disclose
Michele Malagola
No relevant relationships to disclose
Domenico Russo
No relevant relationships to disclose
Mario Tiribelli
No relevant relationships to disclose
Marzia Salvucci
No relevant relationships to disclose
Antonella Vitale
No relevant relationships to disclose
Loredana Elia
No relevant relationships to disclose
Marco Vignetti
No relevant relationships to disclose
Robin FoĆ
No relevant relationships to disclose
Michele Baccarani
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis
Honoraria - Novartis
Giovanni Martinelli
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis
Honoraria - Bristol-Myers Squibb; Novartis